NRBO insider filings

NeuroBo Pharmaceuticals, Inc. — 34 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-09-20. Screen NRBO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for NRBO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — NeuroBo Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2024-09-204DONG-A ST CO., LTD — 10% ownerSale (S): 407 @ $3.75 · Purchase (P): 2,544,530 (derivative) · Purchase (P): 3,816,795 (derivative)EDGAR
2024-08-134Kim Hyung Heon — CEO & President, DirectorTax withholding (F): 11,467 @ $3.60EDGAR
2024-07-104/ADONG-A ST CO., LTD — 10% ownerPurchase (P): 2,544,530 @ $3.93EDGAR
2024-06-254DONG-A ST CO., LTD — 10% ownerPurchase (P): 2,544,530 @ $3.13EDGAR
2024-06-074Salsbury Michael — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-06-074Tursi James Patrick — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-06-074GROVES JASON L — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-06-074Glickman Mark A — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-06-074KOVEN ANDREW I — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-06-074STRICKLAND D GORDON — DirectorGrant/award (A): 5,051 @ $0EDGAR
2024-03-044Woodworth Marshall H — Chief Financial OfficerGrant/award (A): 33,496 @ $0EDGAR
2023-12-044Tursi James Patrick — DirectorGrant/award (A): 25,000 @ $0 · Grant/award (A): 7,157 @ $0EDGAR
2023-08-144Kim Hyung Heon — CEO & President, DirectorGrant/award (A): 625,064 @ $0EDGAR
2023-07-284Salsbury Michael — DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2023-07-284Kim Na Yeon — Director, 10% ownerGrant/award (A): 87,500 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2023-07-284/AKim Na Yeon — Director, 10% ownerOther (J): 4,671 @ $0EDGAR
2023-07-284GROVES JASON L — DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2023-07-284Glickman Mark A — DirectorGrant/award (A): 25,000 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2023-07-284KOVEN ANDREW I — DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2023-07-284STRICKLAND D GORDON — DirectorGrant/award (A): 87,500 @ $0 · Grant/award (A): 12,500 @ $0EDGAR
2022-07-284E&Investment, Inc. — 10% owner
E&Healthcare Investment Fund II — 10% owner
Other (J): 1,445,267 @ $0EDGAR
2022-07-284Kim Na Yeon — Director, 10% ownerOther (J): 1,445,267 @ $0EDGAR
2022-06-134Kim Na Yeon — Director, 10% ownerGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-134GROVES JASON L — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104Kim Hyung Heon — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104Kang Richard — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104Salsbury Michael — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104KOVEN ANDREW I — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104STRICKLAND D GORDON — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-02-024STRICKLAND D GORDON — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-11-044Price Ben Gil — CEO and PresidentGrant/award (A): 616,666 (derivative) @ $0EDGAR
2021-09-034KOVEN ANDREW I — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-01-054Bakshi Akash — SVP and COO, DirectorGrant/award (A): 29,013 · Grant/award (A): 855,059EDGAR
2020-09-034Swirsky Douglas J — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR

Recent 8-K events — NeuroBo Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-11-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-168-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-138-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-128-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-138-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-098-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=NRBO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs